Empaglimet 12.5mg+850mg Tablet is a combination diabetes medicine containing empagliflozin 12.5mg and metformin 850mg. It is used along with diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus.

Empagliflozin belongs to the SGLT2 inhibitor class and helps the kidneys remove excess glucose through urine. Metformin reduces glucose production by the liver and improves the body's response to insulin. Together, these medicines help provide better blood sugar control.

Uses

• Management of type 2 diabetes
• Helps control elevated blood glucose
• Used alongside a healthy diet and regular exercise
• May provide cardiovascular benefits in appropriate patients
• May help reduce certain kidney-related risks in eligible patients

Benefits

• Combines two different diabetes medicines
• Helps improve blood sugar control
• Promotes removal of excess glucose through urine
• Helps reduce glucose production by the liver
• Improves insulin sensitivity
• May provide heart and kidney benefits in appropriate patients

Dosage

• Take Empaglimet 12.5mg+850mg exactly as prescribed by your doctor.
• The dose depends on your blood glucose levels, kidney function, previous treatment, and individual response.
• It is generally taken with food to reduce stomach-related side effects from metformin.
• Swallow the tablet with water.
• Take it at the same time each day as directed.
• Maintain adequate hydration unless your doctor has advised fluid restriction.
• Do not change the dose or stop treatment without medical advice.

Possible Side Effects

Common side effects may include:

• Nausea
• Diarrhea
• Abdominal discomfort
• Increased urination
• Increased thirst
• Urinary tract infections
• Genital fungal infections

Rare but serious complications include lactic acidosis and diabetic ketoacidosis. Seek urgent medical attention for severe weakness, persistent vomiting, abdominal pain, difficulty breathing, confusion, or unusual drowsiness.

Precautions

• Tell your doctor if you have kidney disease, liver disease, heart failure, recurrent urinary or genital infections, or a history of diabetic ketoacidosis.
• Kidney function should be assessed before and during treatment as appropriate.
• Avoid excessive alcohol consumption because it can increase the risk of metformin-associated lactic acidosis.
• Empagliflozin may cause dehydration and low blood pressure.
• Inform your doctor before major surgery or prolonged fasting, as empagliflozin may need to be temporarily stopped.
• Tell your doctor if you are pregnant or breastfeeding.
• This medicine is not intended for treating type 1 diabetes.

FAQs

Q1: What is Empaglimet 12.5mg+850mg Tablet used for?

It is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes.

Q2: What are the ingredients in Empaglimet 12.5mg+850mg?

Each tablet contains empagliflozin 12.5mg and metformin 850mg.

Q3: Should Empaglimet be taken with food?

Yes. Taking the tablet with food can help reduce stomach-related side effects associated with metformin.

Q4: Does Empaglimet cause increased urination?

Yes. Empagliflozin increases the amount of glucose and water eliminated through urine, which can increase urination and thirst.

Q5: Can Empaglimet cause low blood sugar?

The combination has a relatively low risk of hypoglycemia when used alone. However, the risk can increase when it is combined with insulin or certain other diabetes medicines.